Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Korro Bio (KRRO) EBT Margin (2019 - 2025)

Korro Bio's EBT Margin history spans 6 years, with the latest figure at 5294.89% for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin rose 622646.0% year-over-year to 5294.89%, compared with a TTM value of 18.66% through Dec 2025, up 369546.0%, and an annual FY2025 reading of 18.66%, up 369546.0% over the prior year.
  • EBT Margin for Q4 2025 was 5294.89% at Korro Bio, up from 1656.97% in the prior quarter.
  • The five-year high for EBT Margin was 6903.17% in Q1 2023, with the low at 1765.0% in Q2 2025.
  • Average EBT Margin over 4 years is 787.74%, with a median of 677.61% recorded in 2025.
  • Year-over-year, EBT Margin plummeted -37097bps in 2021 and then soared 622646bps in 2025.
  • Tracing KRRO's EBT Margin over 4 years: stood at 187.38% in 2021, then skyrocketed by 3784bps to 6903.17% in 2023, then plummeted by -113bps to 931.57% in 2024, then skyrocketed by 668bps to 5294.89% in 2025.
  • Per Business Quant, the three most recent readings for KRRO's EBT Margin are 5294.89% (Q4 2025), 1656.97% (Q3 2025), and 1765.0% (Q2 2025).